Healthcare

Accelerating the Computing Power Behind Medical Breakthroughs

RH Capital identified Ayar Labs as a foundational technology enabling the next generation of computationally intensive healthcare breakthroughs — from AI-driven drug discovery to large-scale genomic analysis — by replacing the electrical connections between chips with light-based links that move data faster and more efficiently.

The Opportunity

Modern drug discovery and genomic research increasingly depend on AI models too large and too data-intensive for traditional chip architecture to support efficiently. The opportunity belonged to companies solving the underlying data bottleneck constraining every computationally demanding field built on AI — healthcare included.

Why RH Capital Invested

Ayar Labs' optical interconnect technology addresses a problem few companies are solving at the physical layer — the speed and efficiency of chip-to-chip communication that AI-driven healthcare research increasingly depends on. Backing from many of the world's largest chipmakers signaled this was foundational technology, not a niche bet.

Our Role

RH Capital supported Ayar Labs' scaling strategy as the company moved from R&D toward high-volume production, helping connect its technology to the computationally intensive fields — healthcare and life sciences among them — that stand to benefit most.

Execution

Ayar Labs scaled its optical interconnect technology into production and deepened partnerships across the semiconductor industry, expanding the computing capacity available to data-intensive research fields including healthcare and biotechnology.

The Outcome

Ayar Labs has become one of the most closely watched companies in AI infrastructure, with its technology increasingly viewed as essential to sustaining the compute-heavy workloads behind modern medical research.

Looking Ahead

RH Capital continues to focus on the infrastructure layer accelerating breakthroughs across computationally demanding fields — where faster, more efficient computing directly translates into faster scientific and medical progress.

Investing across global markets, partnering with visionary
companies to create sustainable
value for generations.

Office China

Beijing

9FL Jingchao Building
5 Nongzhan South Road
Chaoyang, Beijing, P.R.China 

+86 10 52498156

Office U.S

New York

400 Fifth Ave, #31E
New York, NY 10069
United States 

+1 9174121868

The information provided on this website is for informational and internal discussion purposes only. This content reflects the author's personal views and independent research and does not constitute investment advice, a recommendation, or a solicitation to buy, sell, or hold any security or asset. Nothing herein should be relied upon for making investment decisions, and readers act on this information entirely at their own risk. The content does not represent an official position, forecast, or endorsement of RH Capital as a firm. RH Capital is a management consulting firm and does not provide investment advisory services, manage third-party capital, or engage in fundraising on behalf of any fund, security, or investment vehicle.

© 2026 RH CAPITAL

Subscribe to Our Newsletter.

Investing across global markets, partnering with visionary
companies to create sustainable
value for generations.

Office China

Beijing

9FL Jingchao Building
5 Nongzhan South Road
Chaoyang, Beijing, P.R.China 

+86 10 52498156

Office U.S

New York

400 Fifth Ave, #31E
New York, NY 10069
United States 

+1 9174121868

The information provided on this website is for informational and internal discussion purposes only. This content reflects the author's personal views and independent research and does not constitute investment advice, a recommendation, or a solicitation to buy, sell, or hold any security or asset. Nothing herein should be relied upon for making investment decisions, and readers act on this information entirely at their own risk. The content does not represent an official position, forecast, or endorsement of RH Capital as a firm. RH Capital is a management consulting firm and does not provide investment advisory services, manage third-party capital, or engage in fundraising on behalf of any fund, security, or investment vehicle.

© 2026 RH CAPITAL

Subscribe to Our Newsletter.

Investing across global markets, partnering with visionary
companies to create sustainable
value for generations.

Office China

Beijing

9FL Jingchao Building
5 Nongzhan South Road
Chaoyang, Beijing, P.R.China 

+86 10 52498156

Office U.S

New York

400 Fifth Ave, #31E
New York, NY 10069
United States 

+1 9174121868

The information provided on this website is for informational and internal discussion purposes only. This content reflects the author's personal views and independent research and does not constitute investment advice, a recommendation, or a solicitation to buy, sell, or hold any security or asset. Nothing herein should be relied upon for making investment decisions, and readers act on this information entirely at their own risk. The content does not represent an official position, forecast, or endorsement of RH Capital as a firm. RH Capital is a management consulting firm and does not provide investment advisory services, manage third-party capital, or engage in fundraising on behalf of any fund, security, or investment vehicle.

© 2026 RH CAPITAL

Subscribe to Our Newsletter.

Create a free website with Framer, the website builder loved by startups, designers and agencies.